Skip to content
10-Q

Quarterly Report

MEDICAL EXERCISE INC.

0001213900-25-121625

← back to feed
Filed
Dec 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Dec 15, 2025 12.33M sh
Shares Diluted Q2 2026 · Sep 30, 2025 12.33M sh
Shares Diluted Q2 2026 · Sep 30, 2025 12.31M sh
Shares Diluted Q2 2026 · Sep 30, 2024 12.17M sh
Shares Diluted Q2 2026 · Sep 30, 2024 12.15M sh
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$100.42K
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$102.99K
Cash And Equivalents Q2 2026 · Sep 30, 2025 $23.36K
Cash And Equivalents Q2 2026 · Mar 31, 2025 $450
Stockholders Equity Q2 2026 · Sep 30, 2025 −$211.81K
Stockholders Equity Q2 2026 · Jun 30, 2025 −$127.09K
Stockholders Equity Q2 2026 · Mar 31, 2025 −$67.3K
Stockholders Equity Q2 2026 · Sep 30, 2024 −$64.5K
Stockholders Equity Q2 2026 · Jun 30, 2024 −$5.47K
Stockholders Equity Q2 2026 · Mar 31, 2024 −$52.31K
Current Liabilities Q2 2026 · Sep 30, 2025 $281.31K
Current Liabilities Q2 2026 · Mar 31, 2025 $132.56K
Current Assets Q2 2026 · Sep 30, 2025 $23.36K
Current Assets Q2 2026 · Mar 31, 2025 $450
Total Assets Q2 2026 · Sep 30, 2025 $69.51K
Total Assets Q2 2026 · Mar 31, 2025 $65.26K
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.01
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.01
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.01
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.01
Eps Basic Q2 2026 · Sep 30, 2025 −$0.01
Eps Basic Q2 2026 · Sep 30, 2025 −$0.01
Eps Basic Q2 2026 · Sep 30, 2024 −$0.01
Eps Basic Q2 2026 · Sep 30, 2024 −$0.01
Sga Expense Q2 2026 · Sep 30, 2025 $76.5K
Sga Expense Q2 2026 · Sep 30, 2025 $137.88K
Sga Expense Q2 2026 · Sep 30, 2024 $46.38K
Sga Expense Q2 2026 · Sep 30, 2024 $70.17K
Net Income Q2 2026 · Sep 30, 2025 −$84.72K
Net Income Q2 2026 · Sep 30, 2025 −$155.01K
Net Income Q2 2026 · Sep 30, 2024 −$61.53K
Net Income Q2 2026 · Sep 30, 2024 −$122.19K
Operating Income Q2 2026 · Sep 30, 2025 −$83.85K
Operating Income Q2 2026 · Sep 30, 2025 −$154.14K
Operating Income Q2 2026 · Sep 30, 2024 −$61.92K
Operating Income Q2 2026 · Sep 30, 2024 −$122.58K
Capex Q2 2026 · Sep 30, 2024 $3.87K
Gross Profit Q2 2026 · Sep 30, 2024 $849
Cost Of Revenue Q2 2026 · Sep 30, 2024 $445
Revenue Q2 2026 · Sep 30, 2024 $1.29K